Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Life-saving drug not widely used in Africa - because its too cheap

30.09.2005


Low Cost Fails To Ensure The Availability Of Lifesaving Drug



A life-saving drug used to treat seriously-ill pregnant women in Africa is not widely available – in part because it’s too cheap. Magnesium sulphate is a low-cost but effective treatment for eclampsia and pre-eclampsia in pregnant women. The disease, although relatively rare, claims the lives of more than 63,000 women a year, mostly in poorer countries and can also kill unborn children.

But researchers at the London School of Hygiene & Tropical Medicine (LSHTM), working with colleagues in Mozambique, Zimbabwe, South Africa and Norway, found that availability of the drug is patchy in both Zimbabwe and Mozambique. Writing in this week’s edition of the prestigious British Medical Journal, they said that part of the problem was that because the drug is cheap, pharmaceutical companies do not press for its registration with health authorities or market it widely as the profits to be made from it are small.


But the research team also noted that long delays in registration of drugs, clumsy health bureaucracies in both countries, as well as a lack of financial resources, had also contributed to the poor availability of the drug.

Eclampsia is a condition occurring during or immediately after pregnancy and involving fits which look similar to epilepsy attacks and can kill if not treated. It is associated with pre-eclampsia, with symptoms which may include high blood pressure and protein in the urine as well as intense headaches or visual disturbances. The growth of the unborn baby may also be affected.

But LSHTM researcher Simon Lewin said: “The drug’s low cost means that market forces cannot be relied on to ensure its availability in many places. As initiatives are developed to ensure wider access to expensive drugs critical to improving public health in Africa, low-cost and effective drugs should not be forgotten.”

It is estimated that eclampsia is responsible for more than 11 percent of maternal deaths in Mozambique alone. Public health lecturer Dr. Lewin said that ensuring the availability of effective drugs for priority health problems remained a key issue in Africa. He added: “Even where low-cost, effective treatments exist, drug availability for many common health problems remains poor in many places.”

“Governments, the World Health Organization, international professional organisations such as FIGO (the International Federation of Gynæcology and Obstetrics) and international donor agencies, should take a more active role in ensuring that all essential medicines are registered and available in developing countries.”

And he warned that a failure to address the problem would mean that meeting the Millennium Development Goals on health by the target date of 2015 would become even less likely.

Raymond Hainey | alfa
Further information:
http://www.lshtm.ac.uk

More articles from Health and Medicine:

nachricht Satellites, airport visibility readings shed light on troops' exposure to air pollution
09.12.2016 | Veterans Affairs Research Communications

nachricht Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>